Page 290 - IJB-9-5
P. 290

International Journal of Bioprinting                              Blood components for tissue graft bioprinting



            plasma-based hydrogels. The concentration and the process   physically and chemically crosslinked polymers. They
            temperature directly affect the rheological properties, i.e.,   possess a high water content, which provides a suitable
            viscosity. From a rheological point of view, plasma as a   microenvironment for soluble protein retention (growth
            liquid material presents a complex shear modulus (G*)   factors, chemokines, and cytokines), gradient formation,
            close to zero, increasing in consistency when it is mixed   and diffusion to influence cell behavior and tissue
            with activators such as thrombin or calcium solutions.   repair/regeneration. When mixing biomaterials with
            The clotting of plasma occurs with the conversion of   blood-derived products, the retention/release of healing
            fibrinogen into fibrin. Plasma hydrogels present a non-  factors depends on the plasma formulation and specific
            linear viscoelastic response under shear deformation.  characteristics (functional groups) and processing of the
                                                               hydrogel, i.e., sterilization for clinical translation and
            2.4. Fibrinogen/fibrin                             crosslinking reactions to maintain the stability of the tissue
            Fibrinogen is an abundant blood glycoprotein       constructs.
            (concentration 2.0–4.0 g/L), produced by hepatocytes in
            the liver. It is involved in hemostasis and clot formation.   Knowledge about the anatomy and physiology of the
            Briefly, upon platelet activation, plasma prothrombin   target  tissue  guides  the functionalization strategy and
            converts into thrombin (in the presence of Ca ) and   the choice of inductive tissue components, specific cell
                                                    2+
            cleaves soluble fibrinogen, releasing fibrinopeptides A and   phenotypes, or cell aggregates to be loaded within the
            B. In doing so, thrombin transforms plasmatic fibrinogen   hydrogels. This systematic review reveals that some blood
            into insoluble fibrin networks with large pores and high   biomaterials, such as fibrinogen, are used as inductive
            permeability.  Fibrinogen/fibrin  is  a  crucial  component   elements and to enhance printability, while others are used
            of most blood-derived products but removed in serum-  for printable hydrogel functionalization. In some instances,
            converted fresh-frozen plasma and serum-converted   blood-derived biomaterials are included in the bioink
            platelet lysates (Figure 2).                       formulation, used as a cell carrier in the bioprinting system,
                                                               or added to the bioprinted scaffold. Table 1 summarizes
               Alternatively, purified fibrinogen is prepared by
            cryoprecipitation or chemical precipitation and embodies   research organized by target tissue, and Table 2 lists studies
                                                               involving multipurpose bioinks.
            commercial preparations of fibrin glue or fibrinogen
            adhesives. The latter also includes thrombin and CaCl    In any case, the use of blood-derived biomaterials in
                                                          2
            to be mixed at the point of care for tissue sealing. The   bioprinting platforms has been preliminarily explored to
            resulting fibrin networks are composed of highly branched   meet the specific demands of both soft and hard tissues,
            fibers and are less prone to lysis than plasma clots.  but these approaches are still in the early stages of research
                                                               and far from providing therapeutic solutions. In fact,
            3. Progress in plasma-functionalized               most of the research is in technology readiness level 2–3
                                                               (TRL 2–3), and only one study includes a proof of concept
            bioinks                                            (TRL4)  (reviewed  in  Perez-Valle,  Del  Amo  and  Andia,
            The use of 3D printing/bioprinting in tissue grafting   2020). In vivo studies are needed to assess the integration
            will only grow as new bioinks match the complexity   and function of the construct in animal models mimicking
            and dynamic nature of healing mechanisms. In this   the clinical problem.
            section, we will discuss how SBE printing/bioprinting   Several additives should be included in bioink
            platforms can  benefit from  the  broad  family  of  blood-  formulations  to  fulfill  printability  requirements  and
            derived products and how these products, depending on   match the mechanical properties of the target tissue.
            the specific formulation, can influence printability and   For example, alginate is an anionic polysaccharide and a
            rheology and confer biologically relevant properties on   common ingredient in many bioinks because of its low
            the construct. Thus, the ideal bioink should have several   immunological profile. It is often combined with other
            properties: (i) good printability, (ii) non-toxicity and no   hydrophilic polymers (11 out of 21 studies, 52%), such
            immunological  reactions,  (iii)  good  mechanical  stability   as poly(ethylene glycol) (PEG) for cartilage , gelatin
                                                                                                    [43]
            after curing, (iv) good biodegradability, (v) mimicry   (protein) for dermal tissue , methacrylated gelatin
                                                                                       [44]
            of the  in vivo microenvironment, and (vi) the support   (GelMA) for islet organoids , or agarose (polysaccharide)
                                                                                     [45]
            and  promotion of  cellular  activities  (i.e.,  proliferation,   for  cardiac  tissue   (Table  1).  However,  these  bioinert
                                                                             [46]
            migration, or differentiation).
                                                               hydrogels cannot create biomimetic tissue unless they
               The main bioink component for solvent extrusion is a   are provided with RGD domains for cell attachment and
            shear-thinning hydrogel that can flow during extrusion and   functionalized with cytokines and growth factors to boost
            protect cells from shear stresses. Hydrogels are hydrophilic   cell activities.

            Volume 9 Issue 5 (2023)                        282                         https://doi.org/10.18063/ijb.762
   285   286   287   288   289   290   291   292   293   294   295